The neuroprotective effect of muscarinic transmission is also seen in studies with the 3×Tg-AD mouse model of AD in which, after treatment with an M1 muscarinic agonist, mice showed a decrease in cognitive decline and an accompanying reduction in Aβ and tau pathology [78]. This evidence concerns the gene MAPT and Mental deterioration.